You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Sunovion gets OK for its epilepsy drug

Marlborough firm’s antiseizure medicine expected to reach market early next year

Marlborough biotech Sunovion Pharmaceuticals Inc. is preparing to start selling a new antiseizure pill early next year, following Food and Drug Administration approval of the medication.

FDA regulators signed off on Sunovion’s first epilepsy drug, called Aptiom, on Friday, giving the Japanese-owned company its ninth approved medicine. Those already on the market treat conditions ranging from asthma and insomnia to schizophrenia and bipolar depression.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week